Evidence map›Paper›PMID 42116619›Full record

ArticleChemistry & biodiversity2026

Design, Synthesis, In Vitro, and In Silico Assessment of Fluoroquinolone-Sulfonamide Hybrids as Promising Antibacterial Agents.

Garba Suleiman, Abdelkarim Eljabouri, Abdelali Chihab, Naoual Bentaleb, Abdelmjid Aiboud, Nabil El Brahmi, Saïd El Kazzouli

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Chemistry & biodiversity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Garba SuleimanEuromed Research Center, Euromed University of Fes (UEMF), Fes 30000, Morocco.
Abdelkarim EljabouriThe National Center for Nuclear Energy, Science and Technology, CNESTEN, Rabat, Morocco.
Abdelali ChihabEuromed Research Center, Euromed University of Fes (UEMF), Fes 30000, Morocco.
Naoual BentalebThe National Center for Nuclear Energy, Science and Technology, CNESTEN, Rabat, Morocco.
Abdelmjid AiboudThe National Center for Nuclear Energy, Science and Technology, CNESTEN, Rabat, Morocco.
Nabil El BrahmiEuromed Research Center, Euromed University of Fes (UEMF), Fes 30000, Morocco.
Saïd El KazzouliEuromed Research Center, Euromed University of Fes (UEMF), Fes 30000, Morocco.

Funding

Euromed University of Fes (UEMF), MoroccoNational Center for Nuclear Energy, Science and Technology (CNESTEN)The African Scientific, Research and Innovation Council (ASRIC)
6 · The paper itself

Abstract

A new series of hybrid compounds (1-6) incorporating fluoroquinolone and sulfonamide scaffolds has been synthesized, characterized, and evaluated for antibacterial activity. The analogs were characterized by FT-IR,

Indexed as

Anti-Bacterial AgentsDrug DesignFluoroquinolonesSulfonamidesEscherichia coliMicrobial Sensitivity TestsMolecular Docking SimulationMolecular StructureSalmonella typhimuriumStaphylococcus aureusStructure-Activity RelationshipAnti-Bacterial AgentsFluoroquinolonesSulfonamidesADMETantibacterial activityarylsulfonyl fluoroquinolonesdockingSAR

Identifiers

PMID42116619
PMCPMC13381009

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.